FIRST AMENDMENT TO PATENT AND TECHNOLOGYPatent and Technology • March 31st, 2017 • Q BioMed Inc. • Pharmaceutical preparations
THIS AGREEMENT (the “Amended Agreement”), dated September 6, 2016, amends the Patent and Technology License and Purchase Option Agreement (the “License Agreement”) entered into on May 30, 2016 by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Bio-Nucleonics Inc. (“BNI”) (together, the “Parties”)
PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENTPatent and Technology License And • March 31st, 2017 • Q BioMed Inc. • Pharmaceutical preparations • New York
This Patent and Technology License and Purchase Option Agreement is entered into on June 20, 2016 (“Signing Date”) by and between (i) Q BioMed Inc. (“Q Bio”) and (ii) Bio-Nucleonics Inc. (“BNI”): BNI and Q Bio are hereinafter also referred to individually as a “Party” and collectively as the “Parties.”
